We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform

By LabMedica International staff writers
Posted on 15 Nov 2023
Print article
Image: The miLab AI-based electro-dynamic blood diagnostic platform (Photo courtesy of Noul)
Image: The miLab AI-based electro-dynamic blood diagnostic platform (Photo courtesy of Noul)

Noul Co., Ltd. (Gyeonggi-do, Korea) is showcasing its AI-driven blood and cancer diagnostic platform, miLab, alongside its new product for automatically staining and analyzing cervical cells, at MEDICA 2023.

Based on its AI-based electro-dynamic blood diagnostic platform miLab, Noul offers various solutions. miLab MAL performs diagnostic processes from staining, and digital imaging to AI analysis with ~5µL of blood from fingertips and diagnoses malaria infection within 15 minutes by analyzing up to 300,000 red blood cells. miLab BCM performs diagnostic processes from staining, and digital imaging to AI analysis with ~5µL of blood obtained through fingertips or from veins. It provides high-definition digital images of white blood cells, red blood cells, and platelets, as well as pre-classification. miLab CER performs diagnostic processes from staining, and digital imaging to AI analysis on cervical cells and analyzes each cell’s characteristics to provide analysis results grouped into stages.

Noul’s new product unveiled at MEDICA 2023, ‘miLab Cartridge CER’ is designed for automatically staining and analyzing cervical cells. It stains cervico-vaginal samples smeared manually or by LBC using the Papanicolaou staining combined with NGSI, a solid-based staining technology developed by Noul. When used with miLab, Noul’s AI-based diagnostic platform, it provides staining, imaging, and cell analysis results that assist user’s decision-making. Through the launch of its new product, the company aims to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women.

Related Links:
Noul Co., Ltd. 

Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test
New
Automated Nucleic Acid Extractor
eLab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.